|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Arginase inhibition me diates cardioprotection during ischaemia-reperfusion 显示文摘 | Jung C Gonon AT Sjoquist PO etal | 2010 | Card- iovasc Res2010，85，： | 1 |
| 2 | Effects of angiotensin Ⅱ receptor blocker candesartan on myocardial ischemic/re-perfusion injury显示文摘 | Shimizu M Sjoquist PO Wang QD | | 0，，11： | 1 |
| 3 | Pharmacologicalpossibilities for protection against myocardial reperfusioninjury显示文摘 | Wang QD Pernow J Sjoquist PO | 2002 | Cardiovase Res2002，55，1： | 1 |
| 4 | Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort- acting calcium antagonist for rapid blood pressure control 显示文摘 | Nordlander M Sjoquist PO Ericsson H | 2004 | Cardiovasc Drug Rev2004，22，3： | 1 |
| 5 | Pharmacological possibilities for protection against myocardical reperfusion injury显示文摘 | Wang QD Pernow J Sjoquist PO | 2002 | Cardiovasc Res2002，55，1： | 1 |
| 6 | Pharmacodynamic, pharmacokinetic and clinical effects ofclevidipine, an ultrashort-acting calciumantagonist for rapid blood pressure control显示文摘 | NORD LANDER M SJOQUIST PO ERICSSON H | 2004 | Cardiovasc Drug Rev2004，22，3： | 1 |
| 7 | Myocardioprotective effects of felodipine in an antihypertensive dosage:an experimental study in pigs显示文摘 | Shimizu M Wang QD Sjoquist PO | 1998 | Cardioras Drugs Ther1998，12，1： | 1 |
| 8 | Phar- macodynamic, phar-macokinetic and clinical effects of clevidipine, an uhrashort-acting calciumantagonist for rapid blood pressure control 显示文摘 | Nordlander M Sjoquist PO Ericsson H | 2004 | Cardiovascular Drug Rev2004，22，24： | 1 |
| 9 | Pharmacodynamic, pharmacokinetic and clinical effects of clevidip- ine, an ultrashort-acting calcium antagonist for rapid blood pressure control 显示文摘 | NORDLANDER M SJOQUIST PO ERICSSON H | 2004 | Cardiovasc Drug Rev2004，22，3： | 1 |
| 10 | Pharmacological possibilities for protection against myocardial reperfusion injury显示文摘 | Wang QD Pemow J Sjoquist PO | 2002 | Cardiovase Res2002，55，： | 1 |
| 11 | Pharma- codynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure con- trol显示文摘 | NORDLANDER M SJOQUIST PO ERICSSON H | 2004 | Cardiovase Drug Rev2004，22，3： | 1 |
| 12 | Pharmacological possibilities for protection against myocardial reperfusion injury显示文摘 | Wang QD Pernow J Sjoquist PO | 2002 | Cardiovasc Res2002，55，1： | 1 |
| 13 | A new antioxidant compound H-290151 attenuates spinal cord injury induced expression of constitutive and inducible isoforms of nitric oxide synthase and edema formation in the rat显示文摘 | Sharma HS Sjoquist PO Aim P | 2003 | Acta Neurochir Suppl2003，86，： | 1 |
| 14 | Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion:an experimental study with the ultrashort-acting calcium antagonist clevidipine显示文摘 | Segawa D Sjoquist PO Wang QD | 2000 | J Cardiovasc Pharmacol2000，36，3： | 1 |
| 15 | Pharmacological possibilities for protection againstmyocardial reperfusion injury 显示文摘 | Wang QD Pemow J Sjoquist PO | 2002 | Cardiovasc Res2002，55，1： | 1 |
| 16 | Pharmacological possibilities for protection against myocardial repeffusion injury显示文摘 | Wang QD Pernow J Sjoquist PO | 2002 | Cardiovas Res2002，55，1： | 1 |
| 17 | Pharmacological possibilities for protection against myocardial repedusion injury显示文摘 | Wang QD Pernow J Sjoquist PO | 2002 | Cardiovasc Res2002，55，1： | 1 |
| 18 | Myocardial regeneration with stem cells:pharmacological possibilities for efficacy enhancement显示文摘 | Wang QD Sjoquist PO | 2006 | Pharma-col Res2006，53，4： | 1 |
| 19 | Rosuvastatin protects themyocardium against ischemia-reperfusion injury via inhibition of GGPP synthesis显示文摘 | Bulhak A Sjoquist PO Pernow J | 2004 | Cardiovasc J S Afr2004，15，41： | 1 |
| 20 | Arginase inhibition mediates cardioprotection during ischaemia-reperfusion 显示文摘 | Jung C Gonon AT Sjoquist PO | 2010 | Cardiovasc Res2010，85，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员